Medical Communications

Showing 15 posts of 6411 posts found.

top_ten_1

Top Ten most popular articles on Pharmafile.com this year

December 23, 2016 Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

As we’re now in the New Year, here at Pharmafocus, we thought we would do a recap of the ten …
merrimack-pharmaceuticals

Merrimack’s breast cancer trial stutters to halt

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …
frederik_wilkinson

Impax Laboratories parts with CEO

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Impax Laboratories

Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …
2017

Seven pharma trends for 2017

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2017?Industry uncertaintyPerhaps the biggest hallmark of 2016-going-into-2017 is the sense of hesitation …
novonordiskhq

Fluor wins $2 billion Novo contract to build API manufacturing facility

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fluor, Novo Nordisk, north carolina

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …
jj_2johnson_and_johnson

Actelion acquisition hokey-cokey continues with J&J returning to table

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …
sun_pharma

Sun Pharma to acquire Novartis’s drug for $175 million

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …
novartis_hq_day

Colombian government forces through near half-price cut of Novartis drug

December 21, 2016 Medical Communications, Sales and Marketing Colombia, Novartis

The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …
fdaoutsideweb

FDA new drug approvals sink to six year low

December 21, 2016 Medical Communications, Research and Development FDA, NDA, new drug approvals

The FDA has released figures to show that drug approvals have fallen from last year’s high of 45 new drugs …
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …
640px-prostatic_adenocarcinoma_with_perineural_invasion

Treatment using light and deep-sea bacteria kills cancer cells

December 20, 2016 Medical Communications, Research and Development Vascular-targeted photodynamic therapy

A technique called vascular-targeted photodynamic therapy (VTP) has been developed that sent 49% of patients suffering from prostate cancer into …

Japan announces measure to crack down on drug pricing

December 20, 2016 Manufacturing and Production, Medical Communications Japan, Shinzo Abe, opdivo

Japan has committed to annual drug price reviews whilst also expanding the scope by which the prices are deemed to …
robert_ross_md

Robert Ross joins Surface Oncology as chief medical officer

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio

Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …
nice_reception_small_size

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …
smoke-1001664_1280

FDA removes black box warning on Pfizer’s anti-smoking medication

December 19, 2016 Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking

The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …
The Gateway to Local Adoption Series

Latest content